Historique du chiffre d'affaires, des bénéfices et des flux de trésorerie d'après les états financiers officiels.
Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests.
Voir les graphiques interactifs et les états complets → Modèle de valorisation (DCF) →
| Compte de résultat | TTM → 2026-09-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chiffre d'affaires total | $14.6B | $14.0B | $13.0B | $12.2B | $11.9B | $13.1B | $14.0B | $11.6B | $11.3B | $10.4B | $9.6B | $8.7B | $6.0B | $5.8B | $5.7B | $5.5B | $5.0B | $4.7B | $4.5B | $4.1B | $3.6B |
| Bénéfice brut | $4.1B | $3.7B | $3.6B | $3.4B | $3.7B | $5.0B | $5.0B | $3.3B | $3.2B | $3.5B | $3.2B | $2.9B | $2.2B | $2.2B | $2.2B | $2.3B | $2.1B | $2.0B | $1.9B | $1.7B | $1.5B |
| Marge brute % | 28.0% | 26.8% | 27.9% | 27.7% | 31.3% | 38.0% | 35.4% | 28.1% | 28.0% | 33.2% | 33.0% | 33.5% | 36.6% | 38.3% | 39.7% | 41.0% | 41.9% | 42.0% | 41.6% | 41.6% | 42.6% |
| Résultat opérationnel (EBIT) | $1.6B | $1.5B | $1.1B | $726M | $1.4B | $3.0B | $2.4B | $1.3B | $1.3B | $1.4B | $1.3B | $1.0B | $910M | $991M | $1.0B | $948M | $979M | $936M | $843M | $777M | $697M |
| Marge opérationnelle % | 11.1% | 10.9% | 8.3% | 6.0% | 12.1% | 23.2% | 17.5% | 11.5% | 11.7% | 13.1% | 13.6% | 11.6% | 15.1% | 17.1% | 18.1% | 17.1% | 19.6% | 19.9% | 18.7% | 19.1% | 19.4% |
| Résultat net | $1.0B | $876M | $746M | $418M | $1.3B | $2.4B | $1.6B | $824M | $884M | $1.3B | $732M | $437M | $511M | $574M | $583M | $520M | $558M | $543M | $464M | $477M | $432M |
| Marge nette % | 6.9% | 6.3% | 5.7% | 3.4% | 10.8% | 18.1% | 11.1% | 7.1% | 7.8% | 12.2% | 7.6% | 5.0% | 8.5% | 9.9% | 10.3% | 9.4% | 11.2% | 11.6% | 10.3% | 11.7% | 12.0% |
| EBITDA | — | $2.0B | $1.8B | $1.3B | $2.0B | $3.7B | $3.3B | $2.1B | $2.1B | $1.8B | $1.8B | $1.6B | $1.2B | $1.2B | $1.3B | $1.2B | $1.2B | $1.1B | $1.0B | $990M | $853M |
| Bénéfice par action (EPS) | $12.19 | $10.46 | $8.84 | $4.77 | $13.96 | $24.38 | $15.88 | $8.35 | $8.61 | $12.21 | $7.02 | $4.34 | $5.92 | $6.25 | $5.99 | $5.11 | $5.30 | $4.98 | $4.10 | $3.93 | $3.24 |
| Actions en circulation (M) | — | 84M | 84M | 88M | 92M | 98M | 98M | 99M | 103M | 104M | 104M | 101M | 86M | 92M | 97M | 102M | 105M | 109M | 113M | 121M | 133M |
Source : rapports publics de la société (SEC). Vérifiez sur SEC EDGAR avant de vous fier à tout chiffre.
Bilans, flux de trésorerie, données trimestrielles et ratios complets dans le visualiseur interactif de LH. /companies/us/LH
Les informations de ce site sont fournies à des fins éducatives et informatives uniquement ; elles ne constituent pas un conseil en investissement. Aucun objectif de cours ni recommandation n'est publié.
About TickerBase · Data methodology & sources · Privacy · Terms